News from valeant pharmaceuticals international, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NYSE:VRX,Toronto:VRX)

Jan 25, 2016, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Announces FDA Acceptance of BLA Submission for Brodalumab in Moderate-to-Severe Plaque Psoriasis

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S. Food and Drug Administration (FDA) has...

Jan 25, 2016, 07:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Provides Update On J. Michael Pearson

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today released a memo sent to Valeant employees from J. Michael Pearson,...

Jan 06, 2016, 08:27 ET
Valeant Pharmaceuticals International, Inc.

Valeant Names Howard B. Schiller Interim CEO

Robert Ingram, Lead Independent Director, to Serve as Interim Chairman J. Michael Pearson to Remain on Medical Leave of Absence...

Jan 04, 2016, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Present At The 34th Annual J.P. Morgan Healthcare Conference

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) today announced that members of its senior management team will present at the...

Dec 28, 2015, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Announces J. Michael Pearson Will Be On Medical Leave of Absence

Interim Office of the CEO and Committee of the Board of Directors Formed Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX)...

Dec 16, 2015, 06:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Provides Financial Guidance Update

Conference Call and Webcast to be held at 8:00 am ET today  Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today...

Dec 15, 2015, 08:00 ET
Walgreens

Valeant Announces New U.S. Fulfillment Agreements With Walgreens; Plans To Further Extend Distribution To Independent Pharmacies

Valeant to reduce prices by 10 percent for all dermatological and ophthalmological products distributed through more than 8,000 Walgreens retail...

Nov 20, 2015, 10:26 ET
Valeant Pharmaceuticals International, Inc.

Valeant To Hold Investor Day On December 16

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that the Company will be hosting an Investor Day on December 16,...

Nov 12, 2015, 20:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Present At Industry Conference

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that members of its senior management team will be...

Nov 09, 2015, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant To Hold Conference Call For Investors To Provide Business Update

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that the Company will provide a business update for investors on a...

Nov 06, 2015, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Issues Statement On Sales Of Company Stock

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) stated today that 1,297,399 shares pledged to Goldman Sachs to secure loans made...

Oct 30, 2015, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Former Deputy Attorney General Appointed To Advise Valeant's Ad Hoc Committee

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that the ad hoc committee appointed by Valeant's board of...

Oct 30, 2015, 05:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant To Terminate Relationship With Philidor

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that it is severing all ties with Philidor Rx Services,...

Oct 26, 2015, 09:00 ET
Valeant Pharmaceuticals International, Inc.

Statements Of J. Michael Pearson, Chairman And CEO, And Robert Ingram, Lead Outside Director Of Valeant Pharmaceuticals

 J. Michael Pearson, Chairman and Chief Executive Officer of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX), made the...

Oct 26, 2015, 06:15 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Confirms Appropriateness Of Accounting, Appoints Ad Hoc Board Committee To Review Philidor

VALEANT TO HOLD INVESTOR CONFERENCE CALL AT 8:00 AM ET Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that...

Oct 26, 2015, 06:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Announces The Addition Of G. Mason Morfit To Its Board Of Directors

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced the addition of G. Mason Morfit, President of ValueAct...

Oct 22, 2015, 14:37 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Hold Investor Conference Call On October 26, 2015

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live webcast...

Oct 21, 2015, 13:39 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Responds To Erroneous Report

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today responded to recent accusations made regarding its financial...

Oct 19, 2015, 06:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Reports Third Quarter 2015 Financial Results

2015 Third Quarter Results - Total Revenues of $2.8 billion; an increase of 36% over the prior year despite negative foreign exchange...

Oct 15, 2015, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Synergetics USA, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) today announced that it has completed the previously announced acquisition of...